Skip to main content
Log in

Human angiogenin, an organogenic protein

  • Experimental Oncology
  • Published:
British Journal of Cancer Submit manuscript

Abstract

Angiogenin is a 14 kD protein, initially isolated as a tumour-cell secreted product but subsequently found to be a normal constituent of human plasma. It is a potent inducer of blood vessel formation on the chorioallantoic membrane of the chick embryo. Chemical characterization of the protein reveals a remarkable homology to the pancreatic ribonuclease family and has led to the identification of a unique ribonucleolytic activity for angiogenin. It is a particularly potent inhibitor of in vitro protein synthesis. Treatment with placental ribonuclease inhibitor abolishes the biological and enzymatic activities of angiogenin, an effect with important mechanistic, physiological and pharmacologic implications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

Author information

Authors and Affiliations

Authors

Additional information

Presented, by invitation, at the BACR/CRC/ICRF Symposium in 'Growth factors', London, December 1987.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Riordan, J., Vallee, B. Human angiogenin, an organogenic protein. Br J Cancer 57, 587–590 (1988). https://doi.org/10.1038/bjc.1988.133

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/bjc.1988.133

  • Springer Nature Limited

Navigation